I’ll be honest, there’s something about the word “awareness” that I’ve never really liked – I think it’s because I wish we didn’t have to be aware of kidney cancer. And I suppose it makes sense, because our goal at KCCure is to raise money for research to eliminate kidney cancer – to end the need for an awareness month. But for now, there are too many reminders that it still exists. Spending the day yesterday with a patient, I was reminded how little we know about rare subtypes like Translocation Xp112. At the ASCO-GU conference in Florida last month, we saw papers presented on the need for more knowledge about Renal Medullary Carcinoma, a rare and aggressive variant of kidney cancer. We heard from Dr. Marston Linehan about how far we’ve come in finding genetic ...
After 11 years fighting kidney cancer, the gifts of life are everywhere, even in clinical trials.
As with cancer research, when it comes to fundraising, small advances add up to big change.
For kidney cancer, more research is needed for genomic analysis to inform personalized treatments.
When it comes to kidney cancer care, are patients and caregivers part of the team?
Curing and treating kidney cancer is a two-part challenge: raising research funds and attracting researchers to use them.